U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Animal & Veterinary
  3. News & Events
  4. CVM Updates
  5. FDA Requests Public Comments to Inform Development of National Antimicrobial Resistance Monitoring System (NARMS) Strategic Plan for 2026-2030
  1. CVM Updates

FDA Requests Public Comments to Inform Development of National Antimicrobial Resistance Monitoring System (NARMS) Strategic Plan for 2026-2030

January 8, 2025

The FDA has released a request for comments (RFC) soliciting public input on new opportunities and emergent monitoring needs for possible inclusion in the forthcoming National Antimicrobial Resistance Monitoring System (NARMS) 2026-2030 Strategic Plan.

NARMS is a collaborative program of state and local public health departments and universities, the FDA, the Centers for Disease Control and Prevention (CDC), and the U.S. Department of Agriculture (USDA). This national public health surveillance system tracks changes in the antimicrobial susceptibility of enteric (intestinal) bacteria found in ill people (CDC), retail meats (FDA), and food animals (USDA) in the United States. 

The Federal Register notice about the RFC includes instructions for submitting comments, as well as specific questions and requests for information meant to prompt helpful submissions. The comment period for this RFC opens on January 10, and will be open for 75 days, ending on March 28. Relevant public comments submitted to docket FDA-2024-N-5538 will help inform the development of a draft 2026-2030 NARMS Strategic Plan. NARMS intends to hold a public meeting in the spring of 2025 to share an outline of the draft strategic plan for discussion.   

Additional Information

Issued by FDA Center for Veterinary Medicine. 
For questions, Contact CVM.

Back to Top